Fund Holdings — Atlas Venture Life Science Advisors, LLC

Total Portfolio Value:
$662.35M
Total Bought:
$0
Total Sold:
$4.74M
Net Transaction:
-$4.74M
Securities
▲▼
SharesValue
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Kymera Therapeutics, Inc.(KYMR)4,896,4624,896,4620$134.02M$213.68M32.26%+$79.67M
Disc Medicine, Inc.(IRON)2,384,4562,384,4560$118.36M$126.28M19.07%+$7.92M
Dyne Therapeutics, Inc.(DYN)9,130,4659,130,4650$95.50M$86.92M13.12%-$8.58M
Sionna Therapeutics, Inc.(SION)3,694,0203,694,0200$38.64M$64.09M9.68%+$25.45M
Third Harmonic Bio, Inc.10,402,28610,402,2860$36.10M$56.48M8.53%+$20.39M
Vigil Neuroscience, Inc.5,836,8745,836,8740$10.39M$46.40M7.01%+$36.01M
Day One Biopharmaceuticals, Inc.
COM
6,430,2576,430,2570$50.99M$41.80M6.31%-$9.20M
Korro Bio, Inc.(KRRO)1,137,1491,137,1490$19.80M$14.20M2.14%-$5.59M
Ikena Oncology, Inc.5,018,1785,018,1780$6.42M$6.72M1.02%+$301.1K
Q32 Bio Inc.(QTTB)2,092,1062,092,1060$3.45M$3.12M0.47%-$334.7K
Generation Bio, Co.8,279,4848,279,4840$3.35M$2.65M0.40%-$702.9K
Aerovate Therapeutics, Inc.1,799,2320-1,799,232$4.52M$0—-$4.52M
Spero Therapeutics, Inc.(SPRO)305,2550-305,255$219.8K$0—-$219.8K
Page 1 of 1
Atlas Venture Life Science Advisors, LLC — 13F Holdings — Q2 2025 | TickerTrail